Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 271 AL 285

Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease

Ruthirakuhan M, Herrmann N, Suridjan I, Abraham EH, Farber I, Lanctôt KL.

Expert Opin Pharmacother. 2016 Dec;17(18):2417-2429. doi: 10.1080/14656566.2016.1258060. Epub 2016 Nov 22.

Serum Testosterone and Cognitive Function in Ageing Male: Updating the Evidence

Giagulli VA, Guastamacchia E, Licchelli B, Triggiani V.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):22-30. doi: 10.2174/1872214810999160603213743.

Astrocytes in physiological aging and Alzheimer's disease

Rodríguez-Arellano JJ, Parpura V, Zorec R, Verkhratsky A.

Neuroscience. 2016 May 26;323:170-82. doi: 10.1016/j.neuroscience.2015.01.007. Epub 2015 Jan 14.

Increased libido associated with donepezil treatment: a case report

Segrec N, Zaman R, Pregelj P.

Psychogeriatrics. 2016 Jan;16(1):70-2. doi: 10.1111/psyg.12113. Epub 2015 Mar 3.

The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis

Cheng H, Shang Y, Jiang L, Shi TL, Wang L.

Int J Neurosci. 2016;126(4):299-307. doi: 10.3109/00207454.2015.1015722. Epub 2015 May 22.

Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery

Bu XL, Rao PPN, Wang YJ.

Mol Neurobiol. 2016 Aug;53(6):3565-3575. doi: 10.1007/s12035-015-9301-4. Epub 2015 Jun 23.

Efficacy of Ginkgo biloba extract EGb 761(®) in dementia with behavioural and psychological symptoms: A systematic review

von Gunten A, Schlaefke S, Überla K.

World J Biol Psychiatry. 2016 Dec;17(8):622-633. doi: 10.3109/15622975.2015.1066513. Epub 2015 Jul 30.

Battling Alzheimer's Disease: Targeting SUMOylation-Mediated Pathways

Martins WC, Tasca CI, Cimarosti H.

Neurochem Res. 2016 Mar;41(3):568-78. doi: 10.1007/s11064-015-1681-3. Epub 2015 Jul 31.

Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology

Kamat PK, Kalani A, Rai S, Tota SK, Kumar A, Ahmad AS.

Mol Neurobiol. 2016 Sep;53(7):4548-62. doi: 10.1007/s12035-015-9384-y. Epub 2015 Aug 23.

The genetic landscape of Alzheimer disease: clinical implications and perspectives

Van Cauwenberghe C, Van Broeckhoven C, Sleegers K.

Genet Med. 2016 May;18(5):421-30. doi: 10.1038/gim.2015.117. Epub 2015 Aug 27.

Hybrids: a new paradigm to treat Alzheimer's disease

Singh M, Kaur M, Chadha N, Silakari O.

Mol Divers. 2016 Feb;20(1):271-97. doi: 10.1007/s11030-015-9628-9. Epub 2015 Sep 2.

Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease

Weinreb O, Amit T, Bar-Am O, Youdim MB.

Br J Pharmacol. 2016 Jul;173(13):2080-94. doi: 10.1111/bph.13318. Epub 2015 Dec 1.

Pressure ulcers induced by drug administration: A new concept and report of four cases in elderly patients

Mizokami F, Takahashi Y, Hasegawa K, Hattori H, Nishihara K, Endo H, Furuta K, Isogai Z.

J Dermatol. 2016 Apr;43(4):436-8. doi: 10.1111/1346-8138.13093. Epub 2015 Sep 14.

Cognitive Efficacy (SIB) of 13.3 Versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer's Disease

Isaacson RS, Ferris S, Velting DM, Meng X.

Am J Alzheimers Dis Other Demen. 2016 May;31(3):270-7. doi: 10.1177/1533317515603687. Epub 2015 Sep 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias